Search

Ekaterina M Nikolova

from Rochester, MN
Get Report
Connected to:
Adelina I Nikolova, 55Alisa A Nikolova, 44Bistra N Nikolova, 48Bojan Nikolov, 37Cvetan N Nikolov, 52Daniel M Nikolov, 35Desislava Z Nikolova, 43Dimitar Nikolov, 50Diyan I Nikolov, 49Elian P Nikolov, 64

Ekaterina Nikolova Phones & Addresses

  • Rochester, MN

Work

Company: Department of dermatology, mayo clinic - Rochester, MN Jul 2011 Position: Supervisor - dr. alexander meves

Education

School / High School: Medical University of Sofia 2008 Specialities: PhD

Resumes

Resumes

Ekaterina Nikolova Photo 1

Ekaterina Nikolova

View page
Ekaterina Nikolova Photo 2

Ekaterina Nikolova Rochester, MN

View page
Work:
Department of Dermatology, Mayo Clinic
Rochester, MN
Jul 2011 to Jul 2011
Supervisor - Dr. Alexander Meves
LabCeTi, FUNDP, Namur, Belgium

Sep 2005 to Sep 2006
Supervisor
IN SKIN BIOLOGY

Apr 2003 to Sep 2003
IN SKIN BIOLOGY

2003 to Jan 2003
Department of Chemistry and Biochemistry, Supervisor
Education:
Medical University of Sofia
2008
PhD
University of Sofia
2000
Master in Faculty of Biology

Publications

Us Patents

Methods And Materials For Identifying Malignant Skin Lesions

View page
US Patent:
20190338372, Nov 7, 2019
Filed:
Jul 22, 2019
Appl. No.:
16/518783
Inventors:
- Rochester MN, US
Ekaterina M. Nikolova - Rochester MN, US
International Classification:
C12Q 1/6886
Abstract:
This document provides methods and materials for identifying malignant skin lesions (e.g., malignant pigmented skin lesions). For example, methods and materials for using quantitative PCR results and correction protocols to reduce the impact of basal keratinocyte contamination on the analysis of test sample results to identify malignant skin lesions are provided.

Methods And Materials For Identifying Metastatic Malignant Skin Lesions And Treating Skin Cancer

View page
US Patent:
20170275700, Sep 28, 2017
Filed:
Aug 13, 2015
Appl. No.:
15/503973
Inventors:
- Rochester MN, US
Ekaterina M. Nikolova - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 1/68
C07K 16/30
Abstract:
This document provides methods and materials for identifying metastatic malignant skin lesions (e.g., malignant pigmented skin lesions). For example, methods and materials for using quantitative PCR results and correction protocols to reduce the impact of basal keratinocyte contamination on the analysis of test sample results to identify metastatic malignant skin lesions are provided. This document also provides methods and materials for treating skin cancer. For example, methods and materials for identifying a mammal (e.g., a human) having a pre-metastatic skin lesion (e.g., pre-metastatic melanoma) and treating that mammal with pentamidine (4,4′-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide) are provided.

Methods And Materials For Identifying Malignant Skin Lesions

View page
US Patent:
20160222457, Aug 4, 2016
Filed:
Aug 7, 2013
Appl. No.:
14/442673
Inventors:
- Rochester MN, US
Ekaterina M. NIKOLOVA - Rochester MN, US
International Classification:
C12Q 1/68
Abstract:
This document provides methods and materials for identifying malignant skin lesions (e.g., malignant pigmented skin lesions). For example, methods and materials for using quantitative PCR results and correction protocols to reduce the impact of basal keratinocyte contamination on the analysis of test sample results to identify malignant skin lesions are provided.
Control profile
Ekaterina M Nikolova from Rochester, MN Get Report